【24h】

In vitro experimental photodynamic diagnosis of artery atherosclerosis

机译:动脉粥样硬化的体外实验光动力学诊断

获取原文
获取原文并翻译 | 示例

摘要

Background: Although there are several methods for atherosclerosis detection available, none of them seems to be accurate enough to identify the vulnerable atherosclerotic plaque. Photodynamic diagnosis (PDD) and therapy (PDT) - a new method evaluated for neoplasms treatment is a modem approach to detecting and treating atherosclerosis. Aim: The purpose of this study was to asses in vitro the capability of PDD with use of chloirn e6 to recognize atherosclerotic plaque and its usefulness as a feedback system for photoangioplasty treatment. Methods: 30 specimens of human aorta. The samples were soaked with chlorin e6 and then washed out. The luminescence spectra were then collected. All samples were examined with light microscopy. Results: Tissue fluorescence is seen as green light. We noted a very strong red fluorescence of chlorin e6 originating from lipid reach plaque. We established a quantitative factor which would be the ratio R of chlorin e6 red intensity in its 660 nm maximum compared to the area of green luminescence centred at 515 nm. The highest value of the ratio was reached at atheromatous samples, then calcified and normal ones R_2=3.51 +- 0.62, R_3=1.63 +- 0.31, R_1=1.51+- 0.15 respectively . Statistically significant difference was noted between group two and one and between group two and three R_2=3.51 +- 0.62 vs. R_3=1.63 +- 0.31 (p<0,05); R_2=3.51 +- 0.62 vs. R_1=1.51 +- 0.15 (p< 0.05) respectively. Conclusions: The following in vitro study confirms that photosensitizer chlorin e6 accumulates within atheromatous plaque. It may be a specific tool for atheromatous and normal or calcified segments discrimination. The advantage of the above method is a possibility of a real time imaging followed by targeted therapy of various forms and stages of atherosclerosis.
机译:背景:尽管有几种方法可以检测到动脉粥样硬化,但它们似乎都不够准确,无法识别易损的动脉粥样硬化斑块。光动力诊断(PDD)和治疗(PDT)-一种评估肿瘤治疗的新方法是一种用于检测和治疗动脉粥样硬化的现代方法。目的:本研究的目的是在体外评估chloirn e6识别PDD的能力,以识别动脉粥样硬化斑块及其作为光血管成形术治疗的反馈系统的实用性。方法:30个人主动脉标本。样品用二氢卟酚e6浸泡,然后洗净。然后收集发光光谱。用光学显微镜检查所有样品。结果:组织荧光被视为绿灯。我们注意到源自脂质到达菌斑的二氢卟酚e6发出非常强烈的红色荧光。我们建立了一个量化因子,即以660 nm最大的二氢卟酚e6红色强度与以515 nm为中心的绿色发光面积之比R。在动脉粥样硬化样本上达到该比率的最大值,然后分别钙化和正常钙化,R_2 = 3.51±0.62,R_3 = 1.63±0.31,R_1 = 1.51±0.15。在第二组和一个组之间以及第二组和三个组之间,R_2 = 3.51 +-0.62 vs. R_3 = 1.63 +-0.31(p <0.05),具有统计学意义。 R_2 = 3.51±0.62相对于R_1 = 1.51±0.15(p <0.05)。结论:以下体外研究证实光敏剂二氢卟酚e6积聚在动脉粥样斑块中。它可能是区分动脉粥样硬化和正常或钙化节段的特定工具。上述方法的优点是可以实时成像,然后进行各种形式和阶段的动脉粥样硬化的靶向治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号